Home/Filings/4/0000950170-25-038834
4//SEC Filing

Fountain Tamara 4

Accession 0000950170-25-038834

CIK 0001111485other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 4:46 PM ET

Size

16.3 KB

Accession

0000950170-25-038834

Insider Transaction Report

Form 4
Period: 2025-03-12
Transactions
  • Sale

    Common Stock

    2025-03-12$25.71/sh7,000$180,00224,793 total
Footnotes (2)
  • [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on December 11, 2024 by the Reporting Person.
  • [F2]Represents the weighted average share price of an aggregate total of 7,000 shares sold in the price range of $25.355 to $26.175 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

RxSight, Inc.

CIK 0001111485

Entity typeother

Related Parties

1
  • filerCIK 0001902243

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:46 PM ET
Size
16.3 KB